• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自恒定链p41形式的抑制性片段可在抗原呈递过程中调节半胱氨酸组织蛋白酶的活性。

Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.

作者信息

Mihelic Marko, Dobersek Andreja, Guncar Gregor, Turk Dusan

机构信息

Department of Biochemistry and Molecular and Structural Biology, J Stefan Institute, Ljubljana, Slovenia.

出版信息

J Biol Chem. 2008 May 23;283(21):14453-60. doi: 10.1074/jbc.M801283200. Epub 2008 Mar 24.

DOI:10.1074/jbc.M801283200
PMID:18362148
Abstract

Cysteine cathepsins play an indispensable role in proteolytic processing of the major histocompatibility complex class II-associated invariant chain (Ii) and foreign antigens in a number of antigen presenting cells. Previously it was shown that a fragment of 64 residues present in the p41 form of the Ii (p41 fragment) selectively inhibits the endopeptidase cathepsin L, whereas the activity of cathepsin S remains unaffected. Comparison of structures indicated that the selectivity of interactions between cysteine cathepsins and the p41 fragment is far from being understood and requires further investigation. The p41 fragment has now been shown also to inhibit human cathepsins V, K, and F (also, presumably, O) and mouse cathepsin L with K(i) values in the low nanomolar range. These K(i) values are sufficiently low to ensure complex formation at physiological concentrations. In addition we have found that the p41 fragment can inhibit cathepsin S too. These findings suggest that regulation of the proteolytic activity of most of the cysteine cathepsins by the p41 fragment is an important and widespread control mechanism of antigen presentation.

摘要

半胱氨酸组织蛋白酶在多种抗原呈递细胞中对主要组织相容性复合体II类相关恒定链(Ii)和外来抗原的蛋白水解加工过程中发挥着不可或缺的作用。此前研究表明,Ii的p41形式中存在的一个64个残基的片段(p41片段)可选择性抑制内肽酶组织蛋白酶L,而组织蛋白酶S的活性不受影响。结构比较表明,半胱氨酸组织蛋白酶与p41片段之间相互作用的选择性远未明确,需要进一步研究。现已证明,p41片段还可抑制人组织蛋白酶V、K和F(可能还有O)以及小鼠组织蛋白酶L,其抑制常数(K(i))值处于低纳摩尔范围。这些K(i)值足够低,可确保在生理浓度下形成复合物。此外,我们还发现p41片段也能抑制组织蛋白酶S。这些发现表明,p41片段对大多数半胱氨酸组织蛋白酶蛋白水解活性的调节是抗原呈递的一种重要且广泛存在的控制机制。

相似文献

1
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.来自恒定链p41形式的抑制性片段可在抗原呈递过程中调节半胱氨酸组织蛋白酶的活性。
J Biol Chem. 2008 May 23;283(21):14453-60. doi: 10.1074/jbc.M801283200. Epub 2008 Mar 24.
2
Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.与组织蛋白酶L结合的MHC II类相关p41 Ii片段的晶体结构揭示了组织蛋白酶L和S之间差异的结构基础。
EMBO J. 1999 Feb 15;18(4):793-803. doi: 10.1093/emboj/18.4.793.
3
Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.主要组织相容性复合体II类相关p41恒定链片段是溶酶体组织蛋白酶L的强效抑制剂。
J Exp Med. 1996 Apr 1;183(4):1331-8. doi: 10.1084/jem.183.4.1331.
4
The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.参与MHC II类分子限制性抗原呈递的蛋白水解环境可被恒定链的p41形式调节。
J Immunol. 1996 Oct 15;157(8):3211-5.
5
The p41 fragment story.p41片段的故事。
IUBMB Life. 1999 Jul;48(1):7-12. doi: 10.1080/713803477.
6
Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.人淋巴结中不同巨噬细胞群体中恒定链的抑制性p41亚型及其潜在靶酶组织蛋白酶L和H
Immunology. 2004 Jul;112(3):378-85. doi: 10.1111/j.1365-2567.2004.01879.x.
7
Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.组织蛋白酶S、组织蛋白酶L及恒定链的MHC II类相关p41亚型在人淋巴结组织中的免疫化学定位
Biol Chem. 2001 May;382(5):799-804. doi: 10.1515/BC.2001.096.
8
Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.组织蛋白酶F在巨噬细胞恒定链加工及主要组织相容性复合体II类肽装载中的作用。
J Exp Med. 2000 Apr 3;191(7):1177-86. doi: 10.1084/jem.191.7.1177.
9
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.天冬酰胺内肽酶对II类主要组织相容性复合体(MHC)抗原呈递并非必不可少,但在小鼠中它是组织蛋白酶L加工所必需的。
J Immunol. 2005 Jun 1;174(11):7066-74. doi: 10.4049/jimmunol.174.11.7066.
10
The p41 isoform of invariant chain is a chaperone for cathepsin L.恒定链的p41亚型是组织蛋白酶L的伴侣蛋白。
EMBO J. 2001 Aug 1;20(15):4055-64. doi: 10.1093/emboj/20.15.4055.

引用本文的文献

1
Synthesis of a -Tricarbonylrhenium(I) Complex with Pyrithione, Its Physicochemical Characterization, and Assessment of Biological Effects.α-三羰基铼(I)与吡啶硫酮配合物的合成、物理化学表征及生物效应评估
ACS Omega. 2025 Aug 15;10(33):38272-38291. doi: 10.1021/acsomega.5c06647. eCollection 2025 Aug 26.
2
Apoptotic Caspases-3 and -7 Cleave Extracellular Domains of Membrane-Bound Proteins from MDA-MB-231 Breast Cancer Cells.凋亡性半胱天冬酶-3和-7切割MDA-MB-231乳腺癌细胞膜结合蛋白的细胞外结构域。
Int J Mol Sci. 2025 Apr 8;26(8):3466. doi: 10.3390/ijms26083466.
3
Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.
小分子-肽缀合物作为组织蛋白酶K特异性共价不可逆抑制剂在人破骨细胞和肺癌中的开发与应用
JACS Au. 2025 Mar 3;5(3):1104-1120. doi: 10.1021/jacsau.4c00840. eCollection 2025 Mar 24.
4
Unveiling the Roles of Cysteine Proteinases F and W: From Structure to Pathological Implications and Therapeutic Targets.揭示半胱氨酸蛋白酶 F 和 W 的作用:从结构到病理意义及治疗靶点。
Cells. 2024 May 25;13(11):917. doi: 10.3390/cells13110917.
5
Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors.结构确证和半胱氨酸蛋白酶 L 共价抑制剂的抗病毒活性。
J Med Chem. 2024 May 9;67(9):7048-7067. doi: 10.1021/acs.jmedchem.3c02351. Epub 2024 Apr 17.
6
An Unusual Two-Domain Thyropin from Tick Saliva: NMR Solution Structure and Highly Selective Inhibition of Cysteine Cathepsins Modulated by Glycosaminoglycans.一种来自蜱唾液的不寻常双域甲状腺素:NMR 溶液结构和糖胺聚糖调节的半胱氨酸组织蛋白酶的高选择性抑制。
Int J Mol Sci. 2024 Feb 13;25(4):2240. doi: 10.3390/ijms25042240.
7
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections.卡培他滨是一种有效的组织蛋白酶抑制剂,也是用于治疗 SARS-CoV-2 感染的候选药物。
Commun Biol. 2023 Oct 18;6(1):1058. doi: 10.1038/s42003-023-05317-9.
8
Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins.蛋白质组学数据和结构分析联合揭示了结构刚性和柔性对半胱氨酸组织蛋白酶选择性的相互作用。
Commun Biol. 2023 Apr 24;6(1):450. doi: 10.1038/s42003-023-04772-8.
9
SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity.SARS-CoV-2 刺突介导的进入及其受宿主固有免疫的调节。
Viruses. 2023 Feb 27;15(3):639. doi: 10.3390/v15030639.
10
New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.组织蛋白酶V的新型抑制剂可损害肿瘤细胞增殖和弹性蛋白降解,并增强免疫细胞的细胞毒性。
Comput Struct Biotechnol J. 2022 Aug 28;20:4667-4687. doi: 10.1016/j.csbj.2022.08.046. eCollection 2022.